Health
Regulator-mandated study finds no link between semaglutide use and pancreatic cancer
New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2, found no link between semaglutide use and pancreatic cancer in nationwide registry data from…
AI Summary
A study presented at the European Association for the Study of Diabetes (EASD) Annual Meeting in Milan on September 28 – October 2 found no association between semaglutide use and pancreatic cancer. Researchers analyzed nationwide registry data from Denmark, Sweden, and Norway. The analysis included patients treated with semaglutide across these countries. No increased risk of pancreatic cancer was observed in the registry data. The findings were shared during the EASD conference.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Nearly 1 in 3 Ukrainian civilians meets criteria for PTSD or complex PTSDContinue reading
- Tennessee's failed execution ignites a medical ethics debateContinue reading
- Fluctuations in blood pressure over time linked to death and strokes, analysis of UK data findsContinue reading
- Congress allocated $1.3 billion that the trump administration hasn't spentContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow